Clover Health Investments Corp (NAS:CLOV)

$ 3.17 -0.13 (-3.94%) Market Cap: 1.59 Bil Enterprise Value: 1.32 Bil PE Ratio: 0 PB Ratio: 4.85 GF Score: 34/100

Q3 2024 Clover Health Investments Corp Earnings Call Transcript
Nov 06, 2024

$4.35 (+0.69%)

Earnings
Q2 2024 Clover Health Investments Corp Earnings Call Transcript
Aug 05, 2024

$1.88 (+12.57%)

Earnings
Q1 2024 Clover Health Investments Corp Earnings Call Transcript
May 07, 2024

$0.74 (+2.76%)

Earnings
Q4 2023 Clover Health Investments Corp Earnings Call Transcript
Mar 12, 2024

$0.7675 (-2.66%)

Earnings
Clover Health Investments Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Q3 2023 Clover Health Investments Corp Earnings Call Transcript
Nov 06, 2023

$1.13 (+3.67%)

Earnings
Clover Health Investments Corp at Canaccord Genuity Growth Conference Transcript
Aug 09, 2023
Q2 2023 Clover Health Investments Corp Earnings Call Transcript
Aug 08, 2023

$1.33 (+5.56%)

Earnings
Clover Health Investments Corp at Bank of America Global Healthcare Conference Transcript
May 11, 2023
Q1 2023 Clover Health Investments Corp Earnings Call Transcript
May 09, 2023

$0.93 (+6.09%)

Earnings
Clover Health Investments Corp at Barclays Global Healthcare Conference Transcript
Mar 14, 2023
Clover Health Investments Corp at Citi Healthcare & Medtech Conference Transcript
Mar 01, 2023
Q4 2022 Clover Health Investments Corp Earnings Call Transcript
Feb 28, 2023

$1.32 (+14.78%)

Earnings
Clover Health Investments Corp at JPMorgan Healthcare Conference Transcript
Jan 11, 2023
Clover Health Investments Corp at Credit Suisse Healthcare Conference Transcript
Nov 10, 2022
Q3 2022 Clover Health Investments Corp Earnings Call Transcript
Nov 07, 2022

$1.36 (-0.73%)

Earnings
Q2 2022 Clover Health Investments Corp Earnings Call Transcript
Aug 08, 2022

$3.4 (+4.29%)

Earnings
Clover Health Investments Corp at Bank of America Healthcare Conference Transcript
May 11, 2022
Q1 2022 Clover Health Investments Corp Earnings Call Transcript
May 09, 2022

$2.41 (-10.41%)

Earnings
Clover Health Investments Corp at Barclays Global Healthcare Conference Transcript
Mar 15, 2022
Clover Health Investments Corp at Citi Healthcare Conference (Virtual) Transcript
Feb 24, 2022
Q4 2021 Clover Health Investments Corp Earnings Call Transcript
Feb 23, 2022

$2.01 (-1.47%)

Earnings
Clover Health Investments Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 11, 2022
Clover Health Investments Corp at Credit Suisse Healthcare Conference (Virtual) Transcript
Nov 10, 2021
Q3 2021 Clover Health Investments Corp Earnings Call Transcript
Nov 08, 2021

$8.03 (+2.03%)

Earnings
Q2 2021 Clover Health Investments Corp Earnings Call Transcript
Aug 11, 2021

$8.13 (-3.33%)

Earnings
Q1 2021 Clover Health Investments Corp Earnings Call Transcript
May 17, 2021

Earnings

Q1 2022 Clover Health Investments Corp Earnings Call Transcript

May 09, 2022 / 09:00PM GMT

Release Date Price: $2.41 (-10.41%)

Transcript

Operator

Ladies and gentlemen, good day, and welcome to the Clover Health First Quarter 2022 Earnings Conference Call. (Operator Instructions) As a reminder, today's call is being recorded.

I would now like to turn the call over to Derrick Nueman, Head of Investor Relations and Corporate Strategy for Clover Health. Please go ahead.

Derrick L. Nueman

Clover Health Investments, Corp. - Head of IR & Corporate strategy

Good afternoon, everyone. Joining me on the call today is our CEO, Vivek Garipalli; our President, Andrew Toy; and our Interim CFO, Mark Herbers. We will discuss first quarter results and answer your questions. This call is being recorded.

Before we get started, I would like to remind you that our first quarter's earnings materials, including the release, are available on our website at cloverhealth.com. I'd also like to caution you that we may make forward-looking statements during today's call that are subject to risks and uncertainties, including expectations about future performance. Factors that may cause actual results to differ

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.